ClinConnect ClinConnect Logo
Search / Trial NCT06794203

Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 24, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Hyperthyroidism Kidney Diseases

ClinConnect Summary

This clinical trial is exploring how changes in thyroid function after a kidney transplant might affect the success of the transplant. Researchers want to find out if having hyperthyroidism, a condition where the thyroid gland is overactive, could predict worse outcomes for patients who receive a kidney transplant. They also aim to identify any factors that might increase the risk of thyroid problems during the early recovery period after surgery.

To participate in this study, individuals need to be at least 18 years old and have undergone a kidney transplant at the research center. They should also have available follow-up data from three months after the transplant and consent to be part of the study. Participants will be monitored for changes in their thyroid function within the first month after their surgery, and this will help researchers understand the relationship between thyroid health and kidney transplant success. This research could lead to better care for kidney transplant patients in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects transplanted at our Center;
  • Subjects whose 3-month follow-up is available;
  • Age ≥18 years;
  • Availability of clinical and laboratory data regarding thyroid function trends in the immediate post-transplant period (within 30 days after transplantation);
  • Subjects giving informed consent to participate.
  • Exclusion Criteria:
  • None.

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, , Italy

Patients applied

0 patients applied

Trial Officials

Gaetano La Manna, MD

Principal Investigator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported